SciSparc Ltd. Announces Warrant Exercise Agreement
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from SciSparc Ltd. ( (SPRC) ).
On September 26, 2025, SciSparc Ltd. announced it had entered into inducement offer letter agreements with holders of its existing warrants to purchase up to 361,548 ordinary shares. The holders agreed to exercise their warrants at a reduced price of $3.10 per share, generating approximately $1.12 million in gross proceeds for the company. The transactions are expected to close around September 29, 2025, with the proceeds intended for working capital and general corporate purposes.
More about SciSparc Ltd.
SciSparc Ltd. is a company based in Tel Aviv, Israel, operating in the biotechnology industry. It focuses on the development of therapies for the treatment of disorders of the central nervous system.
Average Trading Volume: 3,991,612
Technical Sentiment Signal: Sell
Current Market Cap: $2.05M
See more data about SPRC stock on TipRanks’ Stock Analysis page.
